World's Best Scientists 2026 revealed!
Tetsuya Hosaka

Tetsuya Hosaka

D-Index & Metrics

Microbiology

D-Index
60
Citations
12604
World Ranking
3133
National Ranking
119

Overview

Tetsuya Hosaka is affiliated with Toranomon Hospital in Japan and has contributed extensively to the field of medicine, with a focus on hepatology, epidemiology, and related disciplines. Their research spans 179 publications primarily centered on liver-related diseases and treatments.

Their work engages deeply with the subfields of epidemiology, hepatology, oncology, pulmonary and respiratory medicine, and endocrinology, diabetes, and metabolism. Key areas of specialization include liver disease diagnosis and treatment, hepatocellular carcinoma treatment and prognosis, hepatitis B virus studies, hepatitis C virus research, pancreatic and hepatic oncology research, liver disease and transplantation, and diet, metabolism, and disease.

Frequent coauthors collaborating with Tetsuya Hosaka include:

  • Fumitaka Suzuki
  • Hiromitsu Kumada
  • Yusuke Kawamura
  • Norio Akuta
  • Hitomi Sezaki

The most common venues for publishing their research are:

  • Hepatology Research
  • Oncology
  • Internal Medicine
  • Liver Cancer
  • Clinical Journal of Gastroenterology

Representative recent papers authored by or involving Tetsuya Hosaka include:

  • "Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis," 2020, The Lancet. Gastroenterology & hepatology
  • "Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis," 2020, The Lancet. Gastroenterology & hepatology
  • "A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial," 2023, Liver Cancer
  • "Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma," 2020, Liver Cancer
  • "SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology," 2020, Internal Medicine

Best Publications

  • Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

    Tetsuya Hosaka;Fumitaka Suzuki;Masahiro Kobayashi;Yuya Seko

  • Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

    Norio Akuta;Fumitaka Suzuki;Miharu Hirakawa;Yusuke Kawamura

  • Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

    Yasuji Arase;Fumitaka Suzuki;Yoshiyuki Suzuki;Norio Akuta

  • Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.

    Yusuke Kawamura;Yasuji Arase;Kenji Ikeda;Yuya Seko

  • Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis

    Yee Hui Yeo;Hsiu J. Ho;Hwai I. Yang;Tai Chung Tseng

  • Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.

    Yasuji Arase;Mariko Kobayashi;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients

    Atsushi Ono;Fumitaka Suzuki;Yusuke Kawamura;Hitomi Sezaki

  • Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B

    Yasuji Arase;Kenji Ikeda;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C

    Yusuke Kawamura;Kenji Ikeda;Yasuji Arase;Hiromi Yatsuji

  • Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.

    Yoshiyuki Suzuki;Mariko Kobayashi;Kenji Ikeda;Fumitaka Suzuki

  • Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment

    Norio Akuta;Fumitaka Suzuki;Mariko Kobayashi;Akihito Tsubota

  • Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection.

    Masahiro Kobayashi;Fumitaka Suzuki;Shunichiro Fujiyama;Yusuke Kawamura

  • Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b

    Fumitaka Suzuki;Hitomi Sezaki;Norio Akuta;Yoshiyuki Suzuki

  • Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b.

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up☆

    Hiromi Yatsuji;Fumitaka Suzuki;Hitomi Sezaki;Norio Akuta

  • Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir.

    Fumitaka Suzuki;Yoshiyuki Suzuki;Norio Akuta;Hitomi Sezaki

Frequent Co-Authors

Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Yoshiyuki Suzuki
Yoshiyuki Suzuki Fukushima Medical University
Yasuji Arase
Yasuji Arase University of Yamanashi
Masahiro Kobayashi
Masahiro Kobayashi Toranomon Hospital
Fumitaka Suzuki
Fumitaka Suzuki Toranomon Hospital
Kenji Ikeda
Kenji Ikeda University of California, San Francisco
Hitomi Sezaki
Hitomi Sezaki Toranomon Hospital
Satoshi Saitoh
Satoshi Saitoh Toranomon Hospital
Mariko Kobayashi
Mariko Kobayashi Kaohsiung Medical University
Yuzo Miyakawa
Yuzo Miyakawa Miyakawa Memorial Research Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond traditional microbiology, several online educational pathways complement this field. Programs like the best online health information management degree cahiim accredited offer specialized training in managing healthcare data, which is increasingly important for microbiologists working in clinical or research settings.

Additionally, accelerated credentials such as the accelerated medical billing and coding certificate online can open doors to administrative roles within healthcare, supporting laboratories and hospitals where microbiology expertise is applied.

For students looking to pursue broader healthcare roles, there are various medical programs online that offer flexibility without compromising quality. These can provide foundational knowledge useful in interdisciplinary fields.

Public health is another vital area where microbiology plays a crucial role. Enrolling in easy mph online programs can equip graduates to address community health challenges, epidemiology, and outbreak control more effectively. Together, these related degrees enhance career opportunities and offer pathways to impactful roles in health sciences.

Best Scientists Citing Tetsuya Hosaka

Trending Scientists